Stock ARCH ARCH BIOPARTNERS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Arch Biopartners Inc. Toronto S.E.

Equities

ARCH

CA03938C1041

Market Closed - Toronto S.E.
Other stock markets
 01:25:20 18/05/2024 am IST 		5-day change 1st Jan Change
1.7 CAD +0.59% Intraday chart for Arch Biopartners Inc. -0.58% +14.86%
16/04 Arch Biopartners Says St. Michael's Hospital Joins Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-AKI MT
16/04 Arch Biopartners Brief: Says St. Michael's Hospital Joins Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury MT

Evolution of the average Target Price on Arch Biopartners Inc.

Price target over the last 5 years

History of analyst recommendation changes

5f9db1246d793379f.8E2U_1wRWTApRX6FOUM4TQw_onX-8h-l_E70ZYBRDkI.g3_kszthDUZhNAi9DRlofWBK7Q3KyynNhSGGLK1kVwaAfffPHUkUV2AADQ~8ae6d18e42c3da4208c80fee6ed4f35d

Analyst Recommendations on Arch Biopartners Inc.

Arch Biopartners Initiated at Market Perform, $3.50 Target Price at Raymond James MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.674 CAD
Average target price
3.5 CAD
Spread / Average Target
+109.14%
High Price Target
3.5 CAD
Spread / Highest target
+109.14%
Low Price Target
3.5 CAD
Spread / Lowest Target
+109.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Arch Biopartners Inc.

Raymond James

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ACHFF Stock
  4. ARCH Stock
  5. Consensus Arch Biopartners Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW